FATP2 regulates osteoclastogenesis by increasing lipid metabolism and ROS production
Journal of Bone and Mineral Research · 23.07.2024 · 39 (6) · 737-752
DOI: 10.1093/jbmr/zjae034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, online erschienen am 05.03.2024. Verfasst von Xiangxi Kong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, 310016, Zhejiang, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Osteoclasts, Osteogenesis, Reactive Oxygen Species. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Anhui Provincial Natural Science Foundation.
Abstract (Originalsprache)
Lipid metabolism plays a crucial role in maintaining bone homeostasis, particularly in osteoclasts (OCs) formation. Here, we found that the expression level of FATP2, a transporter for long-chain and very-long-chain fatty acids, was significantly upregulated during OC differentiation and in the bone marrow of mice fed a high-fat diet (HFD). Notably, the use of FATP2 siRNA or a specific inhibitor (Lipofermata) resulted in significant inhibition of OC differentiation, while only slightly affecting osteoblasts. In pathological models of bone loss induced by LPS or ovariectomy, in vivo treatment with Lipofermata was able to rescue the loss of bone mass by inhibiting OC differentiation. RNA sequencing revealed that Lipofermata reduced fatty acid β-oxidation and inhibited energy metabolism, while regulating ROS metabolism to decrease ROS production, ultimately inhibiting OC differentiation. Treatment with Lipofermata, either in vivo or in vitro, effectively rescued the overactivation of OCs, indicating that FATP2 regulated OC differentiation by modulating fatty acid uptake and energy metabolism. These findings suggested that targeting FATP2 may represent a promising therapeutic approach for pathological osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, 310016, Zhejiang, China.
- Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou 310016, Zhejiang, China.
- Department of Orthopaedic Surgery, Ningbo Medical Center Li Huili Hospital, Ningbo, 315100, Zhejiang, China.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
Zitieren
APA
Kong, X., Tao, S., Ji, Z., Li, J., Li, H., Jin, J., Zhao, Y., Liu, J., Zhao, F., Chen, J., Feng, Z., Chen, B., & Shan, Z. (2024). FATP2 regulates osteoclastogenesis by increasing lipid metabolism and ROS production. Journal of Bone and Mineral Research, 39(6), 737-752. https://doi.org/10.1093/jbmr/zjae034
Vancouver
Kong X, Tao S, Ji Z, Li J, Li H, Jin J, et al. FATP2 regulates osteoclastogenesis by increasing lipid metabolism and ROS production. Journal of Bone and Mineral Research. 2024;39(6):737-752. doi:10.1093/jbmr/zjae034
BibTeX
@article{Kong2024,
author = {Kong, Xiangxi and Tao, Siyue and Ji, Zhongyin and Li, Jie and Li, Hui and Jin, Jiayan and Zhao, Yihao and Liu, Junhui and Zhao, Fengdong and Chen, Jian and Feng, Zhenhua and Chen, Binhui and Shan, Zhi},
title = {FATP2 regulates osteoclastogenesis by increasing lipid metabolism and ROS production},
journal = {Journal of Bone and Mineral Research},
year = {2024},
volume = {39},
number = {6},
pages = {737--752},
doi = {10.1093/jbmr/zjae034}
}
EUVIMED